Diabetes Obes Metab 23(8):18061822 Brock C, Hansen CS, Karmisholt J, Moller HJ, Juhl A, Farmer AD et al (2019) Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy
"(There was) no oversight, no legislation, nobody checking on them, nobody testing the product afterwards or (testing) that it was safe," Clements said
CJC-1295 is not merely "not approved"
Mechanism of Action Comparison# CagriSema# CagriSema combines two distinct appetite-regulating pathways in a single injection
Effective interventions exist, and addressing incontinence early prevents the compensatory behaviors, like limiting fluid intake, that can actually increase UTI risk